Importantly, AKT inhibitors are already in clinical development for other metabolic and oncologic disorders, potentially accelerating drug repurpose efforts
Health Registration: 313M2024 SSA IV
With this in mind, here were going to take a look at the pharmacokinetics of the two big boys (WeGovy and Mounjaro) and think about the impact those may have on the expected effects with type 1, and potentially the corroloary effects when used for other conditions
The real-world picture is already showing up in earnings reports
Keep batteries at 5060% charge in a fireproof LiPo bag or metal container, in a cool (15C25C), dry, ventilated area to ensure safety and longevity
Ask your pharmacy or provider about low dead space options if you are in the starting dose phase